| |
| |
|
| Insider
Information: |
Brown Ryan Edward |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
28,688 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,694,154 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,688 |
|
|
| Total
Value |
$3,694,154 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
|
2024-03-08 |
28,688 |
2021-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2024-03-08 |
4 |
D |
$123.14 |
$110,703 |
D/D |
(899) |
28,688 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2024-03-07 |
4 |
D |
$120.49 |
$60,968 |
D/D |
(506) |
29,587 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2024-03-04 |
4 |
D |
$125.32 |
$217,305 |
D/D |
(1,734) |
30,093 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2024-03-01 |
4 |
D |
$126.19 |
$33,945 |
D/D |
(269) |
27,827 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
33,827 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2024-03-01 |
4 |
S |
$125.34 |
$250,680 |
D/D |
(2,000) |
31,827 |
0 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2023-06-01 |
4 |
D |
$123.60 |
$11,000 |
D/D |
(89) |
28,096 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2023-03-08 |
4 |
D |
$153.19 |
$97,276 |
D/D |
(635) |
28,185 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
28,820 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2023-03-06 |
4 |
D |
$157.21 |
$208,303 |
D/D |
(1,325) |
24,320 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2023-03-01 |
4 |
D |
$147.57 |
$28,924 |
D/D |
(196) |
25,645 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2022-06-01 |
4 |
D |
$72.67 |
$3,924 |
D/D |
(54) |
25,841 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
25,895 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2022-03-07 |
4 |
D |
$79.36 |
$12,142 |
D/D |
(153) |
17,895 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2022-03-04 |
4 |
D |
$79.20 |
$89,971 |
D/D |
(1,136) |
18,048 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2022-03-01 |
4 |
D |
$75.05 |
$13,809 |
D/D |
(184) |
19,184 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2021-06-01 |
4 |
D |
$76.01 |
$4,865 |
D/D |
(64) |
19,368 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2021-03-04 |
4/A |
D |
$80.76 |
$15,344 |
D/D |
(190) |
19,432 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2021-03-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
15,000 |
19,622 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
19,838 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2021-02-28 |
4/A |
D |
$86.97 |
$18,786 |
D/D |
(216) |
4,622 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General CounselOfficer |
• – – |
2021-02-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,838 |
|
% |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
